Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Synucleinopathies”

1,150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,150 results

Testing effectiveness (Phase 2)Study completedNCT00630500
What this trial is testing

Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)

Who this might be right for
Dementia Associated With Parkinson's DiseaseDementia With Lewy Bodies
Helse Stavanger HF 75
Post-approval studies (Phase 4)UnknownNCT03195231
What this trial is testing

Wuling Powder for the Treatment and Underlying Mechanism of Depressive Symptoms in Patients With Parkinson's Disease

Who this might be right for
Antidepressive Agents
Beijing Hospital 120
Not applicableEnded earlyNCT00663312
What this trial is testing

Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
University Hospital, Clermont-Ferrand 8
Not applicableStudy completedNCT02593955
What this trial is testing

The Effects of a High Intensity Exercise Training Program in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Alabama at Birmingham 71
Not applicableUnknownNCT05349539
What this trial is testing

Instrumental Assessment of Motor Symptoms by Means of Wearable Sensors in Patients With Parkinson's Disease

Who this might be right for
Parkinson DiseaseMotor Disorders
Neuromed IRCCS 50
Early research (Phase 1)Study completedNCT03068481
What this trial is testing

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Kissei Pharmaceutical Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT01491932
What this trial is testing

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 129
Testing effectiveness (Phase 2)Study completedNCT02728843
What this trial is testing

Study of Parkinson's Early Stage With Deferiprone

Who this might be right for
Parkinson's Disease
ApoPharma 140
Not applicableStudy completedNCT07006376
What this trial is testing

Thoracolumbar Fascia Thickness in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Ankara University 80
Early research (Phase 1)Study completedNCT02728947
What this trial is testing

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Luye Pharma Group Ltd. 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03683225
What this trial is testing

Evaluate in Patients With Parkinsonian Type Disorders

Who this might be right for
Idiopathic Parkinson Disease
Chase Therapeutics Corporation 24
Not applicableStudy completedNCT03843268
What this trial is testing

Study on the Device "Gondola" for Motor Rehabilitation in Parkinson's Disease

Who this might be right for
Parkinson Disease
IRCCS San Raffaele Roma 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT05104476
What this trial is testing

Lu AF82422 in Participants With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
H. Lundbeck A/S 64
Post-approval studies (Phase 4)Study completedNCT02536976
What this trial is testing

Mirabegron in Parkinson Disease and Impaired Cognition

Who this might be right for
Parkinson DiseaseOveractive BladderImpaired Cognition
HealthPartners Institute 7
Large-scale testing (Phase 3)Ended earlyNCT03901638
What this trial is testing

Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy

Who this might be right for
Ataxia, CerebellarMultiple System Atrophy
National Taiwan University Hospital 18
Not applicableUnknownNCT05784025
What this trial is testing

Gait Training With antiGRAVIty TREadmill 'Alter-G', in Patients With ParkinSON Disease

Who this might be right for
Parkinson Disease
IRCCS Centro Neurolesi Bonino Pulejo 40
Not applicableLooking for participantsNCT06350617
What this trial is testing

Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients

Who this might be right for
Parkinson's Disease and Parkinsonism
Samsung Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00335166
What this trial is testing

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

Who this might be right for
Early Stage Parkinson Disease
Solvay Pharmaceuticals 330
Early research (Phase 1)Study completedNCT01301651
What this trial is testing

Effects of Virtual Reality Training in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Taiwan University Hospital 42
Not applicableLooking for participantsNCT05752656
What this trial is testing

Short- and Long-term Behavioral, Cognitive and Motor Outcomes of Frameless Deep Brain Stimulation in Patients With Parkinson's Disease: a Prospective Observational Study

Who this might be right for
Parkinson Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Load More Results